tert-Butyl 3-(pyrimidin-2-ylamino)azetidine-1-carboxylate

Catalog No. :
ACKTQE510
CAS No. :
1365969-81-8
Molecular Formula :
C12H18N4O2
Molecular Weight :
250.30

IUPAC Name:tert-butyl 3-(pyrimidin-2-ylamino)azetidine-1-carboxylate

tert-Butyl 3-(pyrimidin-2-ylamino)azetidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$371.00Login to see priceInquiryInquiry
250mg95%$643.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 3-(pyrimidin-2-ylamino)azetidine-1-carboxylate
IUPAC Nametert-butyl 3-(pyrimidin-2-ylamino)azetidine-1-carboxylate
MDL No.MFCD21602187
Molecular FormulaC12H18N4O2
Molecular Weight250.30
SMILESO=C(N1CC(NC2=NC=CC=N2)C1)OC(C)(C)C
InChI KeyVFHMEWBMMDQOAT-UHFFFAOYSA-N
Synonymtert-Butyl 3-(pyrimidin-2-ylamino)azetidine-1-carboxylate;1-Azetidinecarboxylic acid, 3-(2-pyrimidinylamino)-, 1,1-dimethylethyl ester
CAS No.1365969-81-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACKTQE510 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRQFJ674 route compound structure diagram
    ACRQFJ674193269-78-2 In Stock
  2. Plus
  3. ACNKTZ369 route compound structure diagram
    ACNKTZ3691722-12-9 In Stock
  4. Then
  5. ACKTQE510 route product structure diagram
    ACKTQE5101365969-81-8
Inquiry

2. ACKTQE510 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRQFJ674 route compound structure diagram
    ACRQFJ674193269-78-2 In Stock
  2. Plus
  3. ACUWYO819 route compound structure diagram
    ACUWYO81931575-35-6 In Stock
  4. Then
  5. ACKTQE510 route product structure diagram
    ACKTQE5101365969-81-8
Inquiry

Comments (0)